Re: Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer?
作者信息
Cassidy Jim, Schmoll Hans-Joachim, Van Cutsem Eric
出版信息
J Clin Oncol. 2008 May 1;26(13):2226-7; author reply 2228. doi: 10.1200/JCO.2008.16.4244.
PMID:18445855
Abstract
摘要
相似文献
1
Re: Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer?
J Clin Oncol. 2008 May 1;26(13):2226-7; author reply 2228. doi: 10.1200/JCO.2008.16.4244.
2
Pharmacoeconomic benefits of capecitabine-based chemotherapy in metastatic colorectal cancer.
J Clin Oncol. 2008 May 1;26(13):2224-6; author reply 2228. doi: 10.1200/JCO.2008.16.2826.
3
Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Con: Pumpin' FU (or, avoiding that oral fixation).
Clin Adv Hematol Oncol. 2005 May;3(5):405-6.
4
Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer?
J Clin Oncol. 2007 Sep 20;25(27):4165-7. doi: 10.1200/JCO.2007.11.6582. Epub 2007 Aug 20.
5
Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: implications for health-care utilization in Australia.
Asia Pac J Clin Oncol. 2013 Sep;9(3):239-48. doi: 10.1111/ajco.12044. Epub 2012 Dec 21.
6
Pharmacoeconomic analysis of capecitabine versus 5-fluorouracil/leucovorin as adjuvant therapy for stage III colon cancer in Taiwan.
Value Health. 2011 Jul-Aug;14(5):647-51. doi: 10.1016/j.jval.2011.01.010. Epub 2011 Jun 22.
7
Capecitabine and oxaliplatin for advanced esophagogastric cancer.
N Engl J Med. 2008 May 1;358(18):1965; author reply 1965. doi: 10.1056/NEJMc080178.
8
Cost-minimisation analysis in first-line treatment of metastatic colorectal cancer in France: XELOX versus FOLFOX-6.
Oncology. 2010;79(3-4):174-80. doi: 10.1159/000325999. Epub 2011 Feb 28.
9
Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement.
BMC Cancer. 2011 Jul 9;11:288. doi: 10.1186/1471-2407-11-288.
10
Patients with locally advanced and metastatic colorectal cancer treated with capecitabine versus 5-fluorouracil as monotherapy or combination therapy with oxaliplatin: a cost comparison.
Clin Colorectal Cancer. 2010 Oct;9(4):229-37. doi: 10.3816/CCC.2010.n.034.
Zotero 插件